限制性股票激励计划
Search documents
华曙高科: 2025年限制性股票激励计划(草案)
Zheng Quan Zhi Xing· 2025-08-27 19:06
Core Viewpoint - The company, Hunan Huashu High-Tech Co., Ltd., has proposed a stock incentive plan involving the grant of 2,962,750 restricted stocks to 95 employees, aimed at enhancing employee motivation and aligning their interests with those of shareholders [2][3][5]. Summary by Sections Incentive Plan Overview - The incentive plan involves granting restricted stocks sourced from the company's repurchase from the secondary market or through directed issuance [2][3]. - The total number of restricted stocks to be granted represents approximately 0.7153% of the company's total share capital of 414,168,800 shares [2][15]. Granting Conditions - The granting price for the restricted stocks is set at 21.90 yuan per share, with adjustments possible based on corporate actions such as stock dividends or capital increases [3][19]. - The plan is designed to motivate core technical personnel and other key employees, excluding external directors and supervisors [4][12]. Performance Metrics - The performance assessment period for the incentive plan spans from 2025 to 2027, with specific targets for net profit margin and revenue growth established for each year [20][24]. - The performance targets include a 10% net profit margin and varying revenue growth rates, starting from 70% in 2025 to 180% in 2027 [20][24]. Management and Approval Process - The plan requires approval from the company's shareholders and must be implemented within 60 days of approval [5][26]. - The board of directors, along with the remuneration and assessment committee, is responsible for overseeing the plan's execution and ensuring compliance with relevant regulations [11][27]. Adjustments and Compliance - Adjustments to the number and price of restricted stocks may occur due to corporate actions such as stock splits or dividends [31]. - The plan includes provisions to terminate or adjust the incentive if the company faces significant financial or regulatory issues [29][30].
天智航: 第六届董事会第二十二次会议决议公告
Zheng Quan Zhi Xing· 2025-08-27 17:10
一、董事会会议召开情况 北京天智航医疗科技股份有限公司(以下简称"公司")第六届董事会第二 十二次会议通知于 2025 年 8 月 19 日以电子邮件方式送达公司全体董事,于 2025 年 8 月 27 日以现场结合通讯方式召开。本次会议应出席董事 9 人,实际出席董 事 9 人,会议由董事长张送根先生主持。本次会议的召集、召开和表决程序符合 《中华人民共和国公司法》《公司章程》的有关规定,会议决议合法有效。 二、董事会会议审议情况 经与会董事表决,形成如下决议: 具体内容详见公司同日刊登在上海证券交易所网站(www.sse.com.cn)的《公 司 2025 年半年度报告》及《公司 2025 年半年度报告摘要》。 表决结果:同意 9 票,反对 0 票,弃权 0 票;通过。 证券代码:688277 证券简称:天智航 公告编号:2025-030 北京天智航医疗科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 本议案已经公司董事会审计委员会审议通过。 告>的议案》 报告期,公司严格按照《募集资金管理办法》及《募 ...
华曙高科: 湖南启元律师事务所关于湖南华曙高科技股份有限公司2024年限制性股票激励计划授予价格调整相关事项的法律意见书
Zheng Quan Zhi Xing· 2025-08-27 16:41
Core Viewpoint - The legal opinion letter from Hunan Qiyuan Law Firm confirms that Hunan Huazhu High-Tech Co., Ltd. has obtained the necessary approvals and authorizations for the adjustment of the grant price of the restricted stock incentive plan for 2024, in compliance with relevant laws and regulations [1][10]. Group 1: Legal Framework and Compliance - The law firm conducted a thorough verification of the facts related to the adjustment of the grant price for the restricted stock, ensuring compliance with the Company Law, Securities Law, and relevant regulations [1][2]. - The law firm has confirmed that the legal opinion is based on the assurance from the company that all necessary and truthful materials were provided, with no significant omissions [2][3]. Group 2: Incentive Plan Details - The 2024 restricted stock incentive plan includes provisions for adjusting the grant price based on various corporate actions such as capital reserve transfers, stock dividends, and other related events [8][9]. - The adjusted grant price for the restricted stock is calculated based on specific formulas that account for dividends and other corporate actions, resulting in a new price of approximately 10.20 yuan per share [9][10]. Group 3: Approval and Implementation - The company has received approval from its shareholders for the profit distribution plan, which includes a cash dividend of 0.49 yuan per 10 shares, impacting the grant price adjustment [9][10]. - The legal opinion letter will be submitted as part of the necessary documentation for the incentive plan and will be disclosed in accordance with legal obligations [2][11].
华曙高科: 湖南启元律师事务所关于湖南华曙高科技股份有限公司2025年限制性股票激励计划(草案)的法律意见书
Zheng Quan Zhi Xing· 2025-08-27 16:41
Core Viewpoint - The legal opinion letter confirms that Hunan Huazhu High-tech Co., Ltd. is qualified to implement the 2025 Restricted Stock Incentive Plan, ensuring compliance with relevant laws and regulations [1][5][25]. Group 1: Company Qualifications - Hunan Huazhu High-tech Co., Ltd. is a legally established and effectively existing listed company with a registered capital of RMB 414.1688 million [4]. - The company has undergone a successful review by the Shanghai Stock Exchange and the China Securities Regulatory Commission, with its stock listed on the Sci-Tech Innovation Board since April 17, 2023 [4][5]. Group 2: Incentive Plan Legality and Compliance - The 2025 Restricted Stock Incentive Plan aims to enhance corporate governance, attract and retain key talents, and align the interests of shareholders, the company, and core team members [7]. - The plan includes 95 incentive targets, primarily core technical personnel, excluding external directors and significant shareholders [8][23]. Group 3: Incentive Plan Details - The total number of restricted stocks to be granted is 2,962,750 shares, accounting for 0.7153% of the company's total share capital [9]. - The grant price for the restricted stocks is set at RMB 21.90 per share, which meets the regulatory requirements [14][20]. Group 4: Performance Assessment - The performance assessment for the incentive plan will be based on annual targets for net profit margin and revenue growth from 2025 to 2027 [17][18]. - Specific performance thresholds must be met for the vesting of shares, with a detailed structure for individual performance evaluations [19][20]. Group 5: Legal Procedures and Disclosure - The company has completed necessary internal decision-making procedures and is in compliance with disclosure obligations regarding the incentive plan [24][25]. - The plan requires further procedures, including shareholder approval, to be fully implemented [21][22].
华曙高科: 2025年限制性股票激励计划实施考核管理办法
Zheng Quan Zhi Xing· 2025-08-27 16:41
Core Viewpoint - The company plans to implement a restricted stock incentive plan for 2025 to enhance corporate governance, attract talent, and align the interests of shareholders, the company, and core team members [1][2]. Group 1: Purpose and Principles of the Incentive Plan - The purpose of the incentive plan is to strengthen the execution of the stock incentive plan, quantify specific goals, and promote scientific and standardized performance management [1][2]. - The assessment principles include fairness, justice, and transparency, linking assessment indicators with the company's long-term strategy and individual performance [2]. Group 2: Assessment Scope and Institutions - The assessment applies to all designated incentive recipients, including core technical personnel and other key individuals, excluding external directors and significant shareholders [2][3]. - The compensation committee of the board is responsible for organizing and implementing the incentive plan, while the human resources department will conduct specific assessments [2][3]. Group 3: Performance Assessment Indicators - The performance assessment for the company will be conducted over three fiscal years (2025-2027), with specific targets set for net profit margin and revenue growth rate [3][4]. - The assessment targets for each year are as follows: - 2025: Net profit margin trigger value at 10%, revenue growth target at 70% - 2026: Net profit margin trigger value at 10%, revenue growth target at 120% - 2027: Net profit margin trigger value at 10%, revenue growth target at 180% [4][5]. Group 4: Individual Performance Assessment - Individual performance assessments will be based on existing company regulations, with results determining the actual number of shares allocated to each recipient [5][6]. - The performance completion rate will categorize individuals into five levels, with corresponding share allocation percentages ranging from 0% to 100% based on performance [5][6]. Group 5: Assessment Period and Procedures - The assessment period for the incentive plan is set for three fiscal years, with annual evaluations for both company-level and individual-level performance [6][7]. - The human resources department will manage the assessment process, and results will be communicated to the assessed individuals within five working days [6][7].
华曙高科: 西部证券股份有限公司关于湖南华曙高科技股份有限公司2024年限制性股票激励计划调整授予价格事项之独立财务顾问报告
Zheng Quan Zhi Xing· 2025-08-27 16:41
Core Viewpoint - The report discusses the adjustment of the grant price for the 2024 Restricted Stock Incentive Plan of Hunan Huashu High-Tech Co., Ltd, highlighting the necessary approvals and the impact of the adjustment on the company's financial status and operational results [6][7]. Summary by Sections Definitions - Key terms such as "Incentive Plan," "Restricted Stock," and "Grant Price" are defined to clarify the context of the report [1]. Independent Financial Advisor's Declaration - The independent financial advisor confirms the legality, accuracy, and completeness of the documents provided for the report, stating that they do not bear any risk responsibility arising from the information [2]. Assumptions - The report is based on several assumptions, including the stability of current laws and regulations, the reliability of the documents provided by the company, and the absence of unforeseen adverse factors [3]. Main Content of the Incentive Plan - The incentive plan has undergone necessary approval procedures, including various resolutions related to the plan and its implementation [4]. Adjustment of Grant Price - The adjustment of the grant price is based on the company's cash dividend distribution of 0.49 RMB per 10 shares, leading to a new grant price of approximately 10.20 RMB per share [6][7]. - The adjustment method follows the formula P = P0 - V, where P0 is the original grant price and V is the dividend per share [6]. Impact of the Adjustment - The adjustment of the grant price is not expected to have a substantial impact on the company's financial condition or operational results, allowing the incentive plan to continue as planned [7]. Independent Financial Advisor's Opinion - The independent financial advisor concludes that the company has fulfilled its disclosure obligations and that the adjustment does not harm the interests of the company or its shareholders [7].
华曙高科: 2025年限制性股票激励计划(草案)摘要公告
Zheng Quan Zhi Xing· 2025-08-27 16:41
Core Points - The company, Hunan Huashu High-Tech Co., Ltd., has announced a new stock incentive plan involving 2,962,750 shares, representing approximately 0.7153% of the total share capital at the time of the announcement [1][3] - The purpose of the incentive plan is to enhance corporate governance, attract and retain key management and technical personnel, and align the interests of shareholders, the company, and the core team [1][2] - The stock incentive plan is independent of the existing 2024 stock incentive plan, which has already granted 4,973,983 shares at a price of 10.25 yuan per share [2][3] Stock Incentive Plan Details - The stock incentive method is classified as second-class restricted stock, which will be granted to eligible participants at a price of 21.90 yuan per share [10][21] - The total number of shares involved in all active incentive plans is 7,936,733, which is about 1.9163% of the company's total share capital [4] - The incentive plan will be valid for a maximum of 48 months from the date of stock grant [6] Eligibility and Distribution - Eligible participants include core technical personnel and other individuals deemed necessary for motivation by the board, excluding external directors and significant shareholders [5][6] - The distribution of the restricted stock will be as follows: 123,750 shares for core technical personnel and 2,839,000 shares for other incentivized individuals [5] Performance Assessment - The performance assessment period for the incentive plan spans from 2025 to 2027, with specific revenue growth targets set for each year [13][16] - The assessment criteria include a minimum revenue growth rate of 10% for the first year, with increasing targets for subsequent years [13][16] Adjustments and Compliance - The number of shares and the grant price may be adjusted in response to corporate actions such as stock splits or capital increases [20][21] - The plan includes provisions for terminating the incentive for participants who do not meet eligibility criteria or who engage in misconduct [25][27]
华曙高科: 关于调整2024年限制性股票激励计划授予价格的公告
Zheng Quan Zhi Xing· 2025-08-27 16:41
Core Viewpoint - The company has adjusted the grant price of its restricted stock incentive plan from 10.25 yuan per share to 10.20 yuan per share due to the implementation of a cash dividend distribution [1][3][4] Group 1: Adjustment Details - The adjustment of the grant price is based on the company's cash dividend distribution of 0.49 yuan per 10 shares, which was implemented on May 8, 2025 [3][4] - The formula used for the adjustment is P = P0 - V, where P0 is the original grant price, V is the cash dividend per share, and P is the adjusted grant price [4] - The adjusted grant price of 10.20 yuan per share remains above the minimum threshold of 1 yuan [4] Group 2: Approval Process - The adjustment was approved by the company's board of directors and the remuneration and assessment committee, confirming compliance with relevant regulations [5] - The supervisory board also reviewed and agreed with the adjustment, stating it does not harm shareholder interests [5] - Legal opinions confirm that the adjustment has received necessary approvals and complies with applicable laws and regulations [6]
威高血净: 山东威高血液净化制品股份有限公司第二届董事会第十三次会议决议公告
Zheng Quan Zhi Xing· 2025-08-27 16:41
Meeting Overview - The second meeting of the board of directors of Shandong Weigao Blood Purification Products Co., Ltd. was held on August 26, 2025, with all 9 directors present [1][2]. Resolutions Passed - The board approved the full and summary reports for the 2025 semi-annual report [2][6]. - The board approved the proposal for the 2025 interim dividend distribution, which will be submitted to the shareholders' meeting for review [2][3]. - The board approved the draft of the 2025 Restricted Stock Incentive Plan and its summary, which will also be submitted to the shareholders' meeting [2][3]. - The board approved the implementation assessment management measures for the 2025 Restricted Stock Incentive Plan, requiring submission to the shareholders' meeting [3][4]. - The board proposed to authorize the board to handle matters related to the 2025 Restricted Stock Incentive Plan, which includes determining eligibility and conditions for participants [4][5]. - The board approved a special report on the management and actual use of raised funds for the first half of 2025 [6][7]. - The board approved the cancellation of the supervisory board and changes to the company's business scope, which will be submitted to the shareholders' meeting [6][7]. - The board approved the nomination of Zhang Zhenhua as an independent director candidate, with an annual allowance of RMB 150,000 [7][8]. - The board proposed to convene the first extraordinary shareholders' meeting of 2025 [7].
百邦科技: 关于2023年限制性股票激励计划首次授予部分第一个归属期归属条件未成就的公告
Zheng Quan Zhi Xing· 2025-08-27 16:41
Summary of Key Points Core Viewpoint The announcement details that the first vesting period conditions for the 2023 restricted stock incentive plan of Beijing Baibao Technology Co., Ltd. have not been met, resulting in the forfeiture of certain granted shares. Group 1: Incentive Plan Overview - The company held a board meeting on August 27, 2025, to discuss the failure of the first vesting period conditions for the 2023 restricted stock incentive plan [1] - The incentive plan was approved during the second extraordinary shareholders' meeting on October 17, 2023, with a total of 278.40 million shares allocated, including 232.00 million shares for the first grant and 46.40 million shares reserved [2][10] - The plan includes various performance targets for vesting, with the first vesting period starting from April 18, 2025, and lasting until October 18, 2025 [9][10] Group 2: Performance Conditions - The performance assessment period for the incentive plan spans from 2024 to 2026, with specific revenue targets set for each year [15] - For the first vesting period, the company must achieve a revenue of at least 600 million yuan in 2024, with a growth rate of no less than 10% in 2025 [16] - The company did not meet the performance targets for 2024, resulting in a 0% vesting rate for the first grant [16] Group 3: Approval and Compliance - The supervisory board confirmed that the failure to meet the performance conditions aligns with the relevant laws and regulations, and does not harm shareholder interests [17] - Legal opinions affirm that the forfeiture of unvested shares complies with the management measures and listing rules [17]